KALER RAY: Open Payments
NPI 1346839495 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 56 payments from 16 companies in 2025. Trend: 2023 $358 · 2024 $444 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $280 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 11 | $81 |
| Ardelyx, Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Janssen Biotech, Inc. | 2 | $55 |
| Enterra Medical, Inc. | 1 | $46 |
| Novo Nordisk Inc | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $40 |
| QOL Medical, LLC | 1 | $27 |
Products named: RINVOQ, ZENPEP, VOQUEZNA, IBSRELA, SKYRIZI, ENTYVIO, TREMFYA, Wegovy.
Industry payments across TN — which companies pay providers there.
